MARKET

RMED

RMED

Ra Medical Systems
NYSE

Real-time Quotes | Nasdaq Last Sale

0.4509
-0.0051
-1.12%
After Hours: 0.4510 +0.0001 +0.02% 19:21 07/10 EDT
OPEN
0.4600
PREV CLOSE
0.4560
HIGH
0.4800
LOW
0.4402
VOLUME
2.08M
TURNOVER
--
52 WEEK HIGH
3.500
52 WEEK LOW
0.3450
MARKET CAP
16.29M
P/E (TTM)
-0.1204
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average RMED stock price target is 1.500 with a high estimate of 2.000 and a low estimate of 1.000.

EPS

RMED News

More
The Law Offices of Frank R. Cruz Announces Investigation of Ra Medical Systems, Inc. (RMED)
The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Ra Medical Systems, Inc. ("Ra Medical" or the "Company") (NYSE: RMED) concerning whether the board breached its fiduciary duty to shareholders.
Business Wire · 06/24 17:23
RA MEDICAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ra Medical Systems, Inc. - RMED
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Ra Medical Systems, Inc. (NYSE: RMED).
Business Wire · 06/20 02:50
Shares Of Nano-Cap Penny Stock Ra Medical Systems Spike, Hearing Buysellshort Issued Positive Alert On Stock
Benzinga · 06/08 13:40
RA MEDICAL INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ra Medical Systems, Inc. - RMED
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Ra Medical Systems, Inc. (NYSE: RMED).
PR Newswire · 05/23 02:50
Ra Medical Systems Announces Closing of $10.0 Million Public Offering
Ra Medical Systems completes $10 million financing.
Business Wire · 05/22 19:23
Ra Medical Systems Receives Continued Listing Standard Notice from the NYSE
Ra Medical Systems, Inc. ("Ra Medical") (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases, today announced
Business Wire · 05/22 10:50
51 Stocks Moving In Thursday's Mid-Day Session
Gainers Seneca Biopharma, Inc. (NASDAQ: SNCA) jumped 99% to $1.6350.
Benzinga · 05/21 17:18
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on May 20.)
Benzinga · 05/21 12:01

Industry

Advanced Medical Equipment & Technology
-0.60%
Healthcare Equipment & Supplies
-0.31%

Hot Stocks

Symbol
Price
%Change

About RMED

Ra Medical Systems, Inc. is a medical device company. The Company is focused on commercializing excimer lasers for use in the treatment of dermatological and vascular diseases. It develops, manufactures and markets medical devices targeting the dermatology and vascular specialties. It operates through two segments: the vascular segment and the dermatology segment. The Company’s laser technology is used for the treatment of psoriasis, vitiligo, atopic dermatitis, leukoderma, and peripheral artery disease (PAD). Its Destruction of Arteriosclerotic Blockages by Laser Radiation Ablation (DABRA) is an excimer laser and disposable catheter system treatment of vascular blockages resulting from lower extremity vascular disease. Pharos is its excimer laser device that emits highly concentrated ultraviolet light and is used as a tool in the treatment of dermatological skin disorders.
More

Webull offers kinds of RA Medical Systems Inc stock information, including NYSE:RMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RMED stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RMED stock methods without spending real money on the virtual paper trading platform.